VivoSim Labs, Inc. Common Stock (VIVS) is a publicly traded Healthcare sector company. As of October 16, 2026, VIVS trades at $0.16 with a market cap of $2.29M and a P/E ratio of -0.03. VIVS moved -9.18% today. Year to date, VIVS is -91.95%; over the trailing twelve months it is -93.99%. Its 52-week range spans $0.15 to $5.30. Rallies surfaces VIVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for VIVS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $0.16 |
| Market Cap | $2.29M |
| P/E Ratio | -0.03 |
| EPS | $-5.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.30 |
| 52-Week Low | $0.15 |
| Volume | 818.27K |
| Avg Volume | 0 |
| Revenue (TTM) | $131.00K |
| Net Income | $-13.84M |
| Gross Margin | 0.00% |
VIVS analyst coverage data. Average price target: $0.00.